BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8706297)

  • 1. Association of HLA-DQA1*0501 with Graves' disease in English Caucasian men and women.
    Barlow AB; Wheatcroft N; Watson P; Weetman AP
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):73-7. PubMed ID: 8706297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human histocompatibility leukocyte antigen-DQA1*0501 allele associated with genetic susceptibility to Graves' disease in a Caucasian population.
    Yanagawa T; Mangklabruks A; Chang YB; Okamoto Y; Fisfalen ME; Curran PG; DeGroot LJ
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1569-74. PubMed ID: 8501164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of an independent association between the human leukocyte antigen allele DQA1*0501 and Graves' disease.
    Cuddihy RM; Bahn RS
    J Clin Endocrinol Metab; 1996 Feb; 81(2):847-9. PubMed ID: 8636314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strong association between HLA-DQA1*0501 and Graves' disease in a male Caucasian population.
    Yanagawa T; Mangklabruks A; DeGroot LJ
    J Clin Endocrinol Metab; 1994 Jul; 79(1):227-9. PubMed ID: 8027232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the HLA-DRB1*0301 and HLA-DQA1*0501 alleles with Graves' disease in a population representing the gene contribution from several ethnic backgrounds.
    Maciel LM; Rodrigues SS; Dibbern RS; Navarro PA; Donadi EA
    Thyroid; 2001 Jan; 11(1):31-5. PubMed ID: 11272094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA DQA1*0501 and DRB1*0301 antigens do not independently convey susceptibility to Graves' disease.
    Philippou G; Krimitzas A; Kaltsas G; Anastasiou E; Souvatzoglou A; Alevizaki M
    J Endocrinol Invest; 2001 Feb; 24(2):88-91. PubMed ID: 11263477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DQ haplotypes in Spanish and German families with Graves' disease: contribution to DQA1*0501-DQB1*0301 mediated genetic susceptibility from fathers.
    Ramos-Lopez E; Fernandez-Balsells M; Kahles H; Seidl C; Ferrer J; Badenhoop K
    Thyroid; 2007 Nov; 17(11):1131-5. PubMed ID: 17714036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human leukocyte antigen HLA DRB3*020/DQA1*0501 haplotype is associated with Graves' disease in African Americans.
    Chen QY; Nadell D; Zhang XY; Kukreja A; Huang YJ; Wise J; Svec F; Richards R; Friday KE; Vargas A; Gomez R; Chalew S; Lan MS; Tomer Y; Maclaren NK
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1545-9. PubMed ID: 10770195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the large multifunctional proteasome (LMP2) gene with Graves' disease is a result of linkage disequilibrium with the HLA haplotype DRB1*0304-DQB1*02-DQA1*0501.
    Heward JM; Allahabadia A; Sheppard MC; Barnett AH; Franklyn JA; Gough SC
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):115-8. PubMed ID: 10468973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA class II alleles in Japanese patients with Graves' disease: weak associations of HLA-DR and -DQ.
    Katsuren E; Awata T; Matsumoto C; Yamamoto K
    Endocr J; 1994 Dec; 41(6):599-603. PubMed ID: 7704083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DRB3*0101 is associated with Graves' disease in Jamaicans.
    Smikie MF; Pascoe RW; Barton E; Morgan O; Christian N; Dowe G; Roye-Green K; Bailey V; James O
    Clin Endocrinol (Oxf); 2001 Dec; 55(6):805-8. PubMed ID: 11895223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HLA-DQ associations with Graves' disease in Chinese children.
    Wong GW; Cheng SH; Dorman JS
    Clin Endocrinol (Oxf); 1999 Apr; 50(4):493-5. PubMed ID: 10468909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HLA association with Graves' disease is sex-specific in Hong Kong Chinese subjects.
    Cavan DA; Penny MA; Jacobs KH; Kelly MA; Jenkins D; Mijovic C; Chow C; Cockram CS; Hawkins BR; Barnett AH
    Clin Endocrinol (Oxf); 1994 Jan; 40(1):63-6. PubMed ID: 8306482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of HLA-DQB and HLA-DPB alleles in Graves' disease by oligonucleotide probing of enzymatically amplified DNA.
    Weetman AP; Zhang L; Webb S; Shine B
    Clin Endocrinol (Oxf); 1990 Jul; 33(1):65-71. PubMed ID: 2401099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivariate analysis of HLA loci in conjunction with a thyrotropin receptor codon 52 polymorphism in conferring risk of Graves' disease.
    Cuddihy RM; Schaid DS; Bahn RS
    Thyroid; 1996 Aug; 6(4):261-5. PubMed ID: 8875744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease.
    Badenhoop K; Walfish PG; Rau H; Fischer S; Nicolay A; Bogner U; Schleusener H; Usadel KH
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2112-7. PubMed ID: 7608264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DQA1*0301-associated susceptibility for autoimmune polyglandular syndrome type II and III.
    Wallaschofski H; Meyer A; Tuschy U; Lohmann T
    Horm Metab Res; 2003 Feb; 35(2):120-4. PubMed ID: 12734793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility alleles and haplotypes of human leukocyte antigen DRB1, DQA1, and DQB1 in autoimmune polyglandular syndrome type III in Japanese population.
    Hashimoto K; Maruyama H; Nishiyama M; Asaba K; Ikeda Y; Takao T; Iwasaki Y; Kumon Y; Suehiro T; Tanimoto N; Mizobuchi M; Nakamura T
    Horm Res; 2005; 64(5):253-60. PubMed ID: 16254435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA class II associations in juvenile Graves' disease: indication of a strong protective role of the DRB1*0701,DQA1*0201 haplotype.
    Lavard L; Madsen HO; Perrild H; Jacobsen BB; Svejgaard A
    Tissue Antigens; 1997 Dec; 50(6):639-41. PubMed ID: 9458117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves' disease: replication using a population case control and family-based study.
    Heward JM; Allahabadia A; Daykin J; Carr-Smith J; Daly A; Armitage M; Dodson PM; Sheppard MC; Barnett AH; Franklyn JA; Gough SC
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3394-7. PubMed ID: 9768636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.